Page last updated: 2024-10-22

amosulalol and Decerebrate Posturing

amosulalol has been researched along with Decerebrate Posturing in 1 studies

amosulalol: RN given is for mono-HCl; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Amosulalol was approximately threefold more potent than labetalol and arotinolol in decreasing blood pressure (BP) in conscious SHR."1.29Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats. ( Honda, K; Inagaki, O; Nakagawa, C; Shibasaki, M; Sudoh, K, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inagaki, O1
Sudoh, K1
Shibasaki, M1
Nakagawa, C1
Honda, K1

Other Studies

1 other study available for amosulalol and Decerebrate Posturing

ArticleYear
Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:5

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypert

1994